SCHEMBL7652392

SCHEMBL7652392

CCCCNS(=O)(=O)c1cc2cc(P(=O)(OCC)OCC)c(=O)[nH]c2cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C19 P33261 2/20 0.37
ALDH1A1 P00352 2/20 0.37
POLB P06746 2/20 0.35
KMT2A Q03164 3/20 0.34
TP53 P04637 2/20 0.34
MEN1 O00255 2/20 0.34
TSHR P16473 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
CA12 O43570 2/20 0.34
CA9 Q16790 2/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA3 P07451 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA5A P35218 1/20 0.34
CA7 P43166 1/20 0.34
CA13 Q8N1Q1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7647829 0.94 POLB (0.37) ALDH1A1POLBTP53TSHRGSTO1
SCHEMBL7647652 0.90 KDM4E (0.38) ALDH1A1POLBTP53KDM4EHSD17B10
SCHEMBL7649180 0.88 GAA (0.39) CYP2C19ALDH1A1POLBTSHRKDM4E
SCHEMBL7651600 0.87 CA12 (0.38) CYP1A2CYP3A4CYP2C19ALDH1A1POLB
SCHEMBL7647190 0.86 GRIN1 (0.35) ALDH1A1KMT2AGSTO1KDM4EHSD17B10
SCHEMBL7652290 0.86 ALDH1A1 (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1POLB
SCHEMBL7648020 0.85 GRIN1 (0.35) ALDH1A1POLBKDM4EHSD17B10HPGD
SCHEMBL7646322 0.85 GRIN1 (0.34) POLBGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7645904 0.84 GSTO1 (0.34) ALDH1A1GSTO1GRIN2DGRIN3BGRIN1
SCHEMBL6926207 0.83 GRIN1 (0.38) CYP1A2ALDH1A1POLBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486143-B2 NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS LES LABORATOIRES SERVIER (FR) 2002-11-26 US disclosed
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds LES LABORATOIRES SERVIER (FR) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds CA6, P2RY6, FPR3 CYP1A2 2089/4885CYP3A4 1361/4885CYP2C19 896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.